GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:OPXA
Delisted

Opexa Therapeutics Fund Forecast

$0.97
+0 (+0%)
At Close: Jan 16, 2018
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Opexa Therapeutics Fund and on which exchange is it traded?
The symbol for Opexa Therapeutics is OPXA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Opexa Therapeutics Fund?
Opexa Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Opexa Therapeutics Fund?
Opexa Therapeutics Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Opexa Therapeutics Fund.

What's the current price of Opexa Therapeutics Fund?
As of the end of day on the 2018-01-16, the price of an Opexa Therapeutics (OPXA) share was $0.97.

What is the 52-week high and low for Opexa Therapeutics Fund?
The 52-week high for Opexa Therapeutics Fund is $1.45 and the 52-week low is $0.550.
Click to get the best stock tips daily for free!

About Opexa Therapeutics

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. The company’s lead product candidate is Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. It is also developing OPX-212 as an autologous T-cell immunotherapy t... OPXA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT